how realistic is dso, page-3

What are you on about? MAK should sell non-phosphate prospects because the market is weak? MAK have some cash, they are on track and their other assets are worth keeping - especially in this weak market. The BFS should tell any prospective lender the value of a relationship with MAK - thats the bottom line.

Patience should be the name of the game. Their are already signs of a recovery - despite articles to the contrary - banks are lending again (slowly) and the DOW has settled somewhat, from its huge swings. There will be a new president in the white house and out troops will be coming home soon (although Afghanistan looms still).

BTW, the difference between DSO and beneficiation pathway's? Surely DSO is a subset of the beneficiation cost and therefore DSO first will not entail any additional costs and most likely will result in early returns.

Is this a fundamental change of heart?